The absence of α-thalassemia and glucose-6-phosphate dehydrogenase (G6PD) deficiency could increase the risks for stroke by modulating the level of hemolysis, oxidative stress and blood rheology (Connes et al., 2013). The gene discussed is G6PD; the disease is G6PD deficiency.